Capsid-incorporation of antigens into adenovirus capsid proteins for a vaccine approach. - Wikidata - awgldk - TriplyDB

Capsid-incorporation of antigens into adenovirus capsid proteins for a vaccine approach.

Capsid-incorporation of antigens into adenovirus capsid proteins for a vaccine approach.

http://www.wikidata.org/entity/Q37806749

about

A recombinant adenovirus-based vector elicits a specific humoral immune response against the V3 loop of HIV-1 gp120 in mice through the "Antigen Capsid-Incorporation" strategy.Generation of neutralizing monoclonal antibodies against a conformational epitope of human adenovirus type 7 (HAdv-7) incorporated in capsid encoded in a HAdv-3-based vector.Protection against enterovirus 71 with neutralizing epitope incorporation within adenovirus type 3 hexon.Adenovirus-based vaccine with epitopes incorporated in novel fiber sites to induce protective immunity against Pseudomonas aeruginosa Using multivalent adenoviral vectors for HIV vaccination Protection of adenovirus from neutralizing antibody by cationic PEG derivative ionically linked to adenovirus Critical Role of Autophagy in the Processing of Adenovirus Capsid-Incorporated Cancer-Specific Antigens A Plasmodium Promiscuous T Cell Epitope Delivered within the Ad5 Hexon Protein Enhances the Protective Efficacy of a Protein Based Malaria Vaccine Identification and Application of Neutralizing Epitopes of Human Adenovirus Type 55 Hexon Protein.Antigen capsid-display on human adenovirus 35 via pIX fusion is a potent vaccine platform.Covalent decoration of adenovirus vector capsids with the carbohydrate epitope αGal does not improve vector immunogenicity, but allows to study the in vivo fate of adenovirus immunocomplexes Interaction between hexon and L4-100K determines virus rescue and growth of hexon-chimeric recombinant Ad5 vectors Adenovirus: the first effective in vivo gene delivery vector Modeling pre-existing immunity to adenovirus in rodents: immunological requirements for successful development of a recombinant adenovirus serotype 5-based ebola vaccine.Progress and prospects: hurdles to cardiovascular gene therapy clinical trials.Progress on adenovirus-vectored universal influenza vaccines.Future Prospects for the Development of Cost-Effective Adenovirus Vaccines.Novel viral vectors in infectious diseases.Exploration of New Sites in Adenovirus Hexon for Foreign Peptides Insertion.Chimpanzee adenoviral vectors as vaccines for outbreak pathogens.

P2860

Q33786140-B3449EF7-3A50-4AE1-A285-6160667BAA3E Q33940167-FF967620-7C81-4961-9E90-988FF0E434CC Q34358402-C0199B86-25C0-4299-97C9-8EB856FEBF1B Q34599868-F8A2F2B6-BF67-46CA-886E-CC286AEC2DB7 Q34653777-E10F5E7C-7132-4CF7-AD68-282C6229F9BF Q35821087-7FBD6F3D-DCAD-4D72-81E9-5F5A69851390 Q35993889-4C9678FB-C5F8-45B6-8E5F-6AE568ED6117 Q36003208-FB0216E3-0D2E-4479-85E3-DE1759C43287 Q36246676-DF65C67A-EB98-43B3-B7D4-731941F2760E Q36330007-9556D82F-1D6A-4ED8-8DF6-C3F9BBF6CD44 Q36363270-487D4073-B466-47CE-A70C-209AD7E86400 Q36645405-4FC2BFA4-1261-4199-806C-9FC470C7CD76 Q37508260-1B262440-5F1B-4468-B4A8-D0D7AF50CA73 Q37627897-1C3CF1C2-6421-4567-8B20-51282FC10193 Q37864925-3CED2992-3326-438C-AFFB-E4E0CF509929 Q38421971-79057E71-0669-474A-A380-9D0E7B3FC061 Q38728732-85EAEFBC-C3F2-46AA-B0AA-894712BC2F27 Q40059020-2A15725F-1A6D-4DE9-BFC8-292B066B5A6A Q41165765-EB5FEA94-4BEC-4858-8BAE-59FD682AB0D8 Q44106019-397085E4-41FD-4172-B327-2DAD424386ED

P2860

Capsid-incorporation of antigens into adenovirus capsid proteins for a vaccine approach.

http://www.wikidata.org/entity/Q37806749

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Capsid-incorporation of antigens into adenovirus capsid proteins for a vaccine approach.

@en

Capsid-incorporation of antigens into adenovirus capsid proteins for a vaccine approach.

@nl

type

label

Capsid-incorporation of antigens into adenovirus capsid proteins for a vaccine approach.

@en

Capsid-incorporation of antigens into adenovirus capsid proteins for a vaccine approach.

@nl

prefLabel

Capsid-incorporation of antigens into adenovirus capsid proteins for a vaccine approach.

@en

Capsid-incorporation of antigens into adenovirus capsid proteins for a vaccine approach.

@nl

P1433

Q37806749-6680F361-E5A0-4E51-AE32-2B53B518A305

P1476

Q37806749-CAB04644-E1BE-4479-B288-6F142C6491BF

P2093

Q37806749-325440D4-5E8B-4B0B-8CD6-7AF411E17523

P2860

Q37806749-006FDDB0-C219-422F-B7B9-5D4C7CFF153D

Q37806749-03A42EFB-BDAF-4C17-8A1A-BF20A2F5F56E

Q37806749-04BE40E0-D56E-4C61-9F1C-4C77E985F432

Q37806749-08611CDD-53B9-48E4-8CF6-A3E2B568E616

Q37806749-0F043229-4236-4D86-B2CD-95C383E7199A

Q37806749-18C10BFD-4342-43BE-90A0-55F829C6600A

Q37806749-1A0294BE-65BC-465C-85C6-A6464A7F77D1

Q37806749-208708CD-1C28-45D1-BD48-3BD281D74B1E

Q37806749-225B819D-A227-4C56-9FCA-5119B0430A18

Q37806749-24579701-6A1F-4206-A896-77E326891192

P304

Q37806749-487E87DD-7488-4423-B49F-2B7034D72F90

P31

Q37806749-9CA0D1E8-4018-4697-8512-5DEC6C51D112

P356

Q37806749-85F96B3C-8DB1-4E00-84DF-D127368317FF

P407

Q37806749-E3C2FDBA-A7A0-4022-8A96-1ED69D4887E1

P433

Q37806749-E3E9306A-2E0E-4787-9BC9-A39AED982D56

P478

Q37806749-AC4D81E1-A260-4FAC-8296-F36A6D29C0F5

P577

Q37806749-8A10E98F-9EA5-4C53-995A-A47FDD6E7CF0

P698

Q37806749-C6E1B540-87B4-408F-8463-7F040A9B24AF

P921

Q37806749-ED832D9F-B763-489A-92E9-936A1BC655A9

P932

Q37806749-7797E677-3F67-4CE1-B573-2A06E62C5683

P356

P1433

Molecular Pharmaceutics

P1476

Capsid-incorporation of antigens into adenovirus capsid proteins for a vaccine approach.

@en

P2093

Qiana L Matthews

http://www.w3.org/2001/XMLSchema#string

P2860

Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution x-ray crystallographic, molecular modeling, and sequence-based methods

Structure of the human adenovirus serotype 2 fiber head domain at 1.5 A resolution

Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR

Structure of the fiber head of Ad3, a non-CAR-binding serotype of adenovirus

Crystal structure of the receptor-binding domain of adenovirus type 5 fiber protein at 1.7 A resolution

Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics

Induction of neutralizing antibody responses to anthrax protective antigen by using influenza virus vectors: implications for disparate immune system priming pathways

Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in Africa

Cell-free transmission in adult Swiss mice of a disease having the character of a leukemia.

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

P304

3-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/MP100214B

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21047139

http://www.w3.org/2001/XMLSchema#string

P921

P932

3034826

http://www.w3.org/2001/XMLSchema#string